Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal pigment epithelium-specific 65 kDa protein (RPE65) is a critical enzyme in the vertebrate visual cycle, primarily expressed in the retinal pigment epithelium (RPE). It functions as a retinoid isomerohydrolase, catalyzing the conversion of all-trans-retinyl esters to 11-cis-retinol, which is essential for regenerating visual pigments after light exposure. Mutations in RPE65 are linked to inherited retinal diseases like Leber congenital amaurosis type 2 (LCA2) and retinitis pigmentosa.
RPE65 catalyzes the conversion of all-trans-retinyl esters to 11-cis-retinol, a crucial step in regenerating visual pigments for light detection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal pigment epithelium-specific 65 kDa protein (RPE65).